| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.12 | 0.04 |